Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.400, 2003-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Initiating HAART earlier a prudent move in HIV infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 489, 2005-01 ,pp. :
Access to resources
Recommend
HAART prescribing below par for HIV infections in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 417, 2003-01 ,pp. :
Enfuvirtide: cost and QOL effect in HIV infections
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
Enfuvirtide: cost and QOL effect in HIV infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. :
Efavirenz- and nevirapine-based HAART equally effective in HIV infections
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :